Detalhe da pesquisa
1.
Activity of afatinib in patients with NSCLC harboring novel uncommon EGFR mutations with or without co-mutations: a case report.
Front Oncol
; 14: 1347742, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38769948
2.
Sotorasib in KRAS G12C-mutated non-small cell lung cancer: A multicenter real-world experience from the compassionate use program in Germany.
Eur J Cancer
; 201: 113911, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38377774
3.
The Combined Therapy of Cabozantinib, Crizotinib, and Osimertinib in a Lung Cancer Patient with Acquired MET Amplification and Resistance Mutations.
Curr Oncol
; 30(10): 8805-8814, 2023 09 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37887535
4.
NSCLC with uncommon EGFR mutations treated with atezolizumab plus bevacizumab and chemotherapy.
Lung Cancer
; 174: 141-145, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36402005
5.
Clinical Post-SARS-CoV-2 Infection Scenarios in Vaccinated and Non-Vaccinated Cancer Patients in Three German Cancer Centers: A Retrospective Analysis.
Cancers (Basel)
; 14(15)2022 Jul 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-35954410
6.
Durvalumab after definitive chemoradiotherapy in locally advanced NSCLC: Data of the German EAP.
Data Brief
; 34: 106556, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33364266
7.
Efficacy of docetaxel plus ramucirumab as palliative second-line therapy following first-line chemotherapy plus immune-checkpoint-inhibitor combination treatment in patients with non-small cell lung cancer (NSCLC) UICC stage IV.
Transl Lung Cancer Res
; 10(7): 3093-3105, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34430350
8.
Diagnostic, Clinical and Post-SARS-CoV-2 Scenarios in Cancer Patients with SARS-CoV-2: Retrospective Analysis in Three German Cancer Centers.
Cancers (Basel)
; 13(12)2021 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34208007
9.
Comparison of Resistance Spectra after First and Second Line Osimertinib Treatment Detected by Liquid Biopsy.
Cancers (Basel)
; 13(12)2021 Jun 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34201252
10.
KRAS G12C-mutated advanced non-small cell lung cancer: A real-world cohort from the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315).
Lung Cancer
; 154: 51-61, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33611226
11.
Efficacy of Docetaxel Plus Ramucirumab as Palliative Third-Line Therapy Following Second-Line Immune-Checkpoint-Inhibitor Treatment in Patients With Non-Small-Cell Lung Cancer Stage IV.
Clin Med Insights Oncol
; 14: 1179554920951358, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32884390
12.
Durvalumab after definitive chemoradiotherapy in locally advanced unresectable non-small cell lung cancer (NSCLC): Real-world data on survival and safety from the German expanded-access program (EAP).
Lung Cancer
; 150: 114-122, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33126091
13.
Integration of Tumor Mutation Burden and PD-L1 Testing in Routine Laboratory Diagnostics in Non-Small Cell Lung Cancer.
Cancers (Basel)
; 12(6)2020 Jun 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32599951
14.
Effect of preoperative chemoradiation in addition to preoperative chemotherapy: a randomised trial in stage III non-small-cell lung cancer.
Lancet Oncol
; 9(7): 636-48, 2008 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-18583190
15.
First-line systemic treatment with gefitinib in stage IV non-small cell lung cancer.
Oncol Rep
; 14(6): 1539-42, 2005 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-16273252
16.
Efficacy of the irreversible ErbB family blocker afatinib in epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI)-pretreated non-small-cell lung cancer patients with brain metastases or leptomeningeal disease.
J Thorac Oncol
; 10(1): 156-63, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25247337
17.
Signal transduction pathways as novel therapy targets in lung cancer.
Lung Cancer
; 45 Suppl 2: S177-86, 2004 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-15552798
18.
Non-small-cell lung cancer: multimodality approach in stage-III resectable disease.
Lung Cancer
; 45 Suppl 2: S99-105, 2004 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-15552789
19.
Combined modality treatment for locally advanced non-small cell lung cancer: preoperative chemoradiation does not result in a poorer quality of life.
Lung Cancer
; 44(1): 89-97, 2004 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15013587
20.
Preoperative chemotherapy with and without additional radiochemotherapy: benefit and risk for surgery of stage III non-small cell lung cancer.
Eur J Cardiothorac Surg
; 26(6): 1205-1210, 2004 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-15678591